Laddar...
Acute coronary syndrome after infliximab therapy in a patient with Crohn’s disease
Infliximab is a potent anti-TNF antibody, which is used with great success in Crohn’s disease patients. Since its release in clinical practice, several adverse reactions have been observed. The interest in possible consequences of its administration is still high because of the recent introduction o...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Co., Limited
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4088126/ https://ncbi.nlm.nih.gov/pubmed/17036404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i38.6235 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|